Nektar Therapeutics | 净收入

股票价格
71.33
每天变化
0.33 0.46%
每月一次
97.64%
每年
383.95%
Q1 预测
69.12


金融业
股票价格
USD
资产
USD 301.35M
现金及等价物
USD 41.03M
销售成本
USD 4.44M
流动资产
USD 281.36M
流动负债
USD 66.34M
债务
USD 0
股息收益率
0
EBIT
USD -34.35M
EBITDA
USD -31.81M
员工
137
EPS每股收益
USD -0.18
股本和储备
USD 85.09M
销售毛利
USD 13.75M
债务利息支出
USD 6.02M
利息收入
USD -0.18
贷款资金
USD 107.51M
市值
USD 13.04B
净收入
USD -37.06M
营业费用
USD 85.09M
营业利润
USD -34.35M
普通股股本
USD 19K
税前利润
USD -37.05M
销售收入
USD 24.12M
销售和管理费用
USD -0.18
股票
USD 14.46M
贸易债权人
USD 15.56M
应收帐款人
USD 0


净收入 更改 日
Agios Pharmaceuticals USD -108.04M 4.61M 2025-12
ALKERMES USD 82.76M 4.34M 2025-09
Alterity Therapeutics Limited AUD -5.77M 2.26M 2023-06
Amgen USD 1.33B 1.88B 2025-12
Baxter International USD -1.13B 1.08B 2025-12
BioCryst Pharmaceuticals USD -88.88M 74.85M 2024-12
Biogen USD 466.5M 168.3M 2025-09
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Cara Therapeutics USD -4.91M 2.77M 2025-03
Cipla INR 6.76B 6.75B 2025-12
Dr.Reddys Laboratories INR 12.1B 2.27B 2025-12
Eisai JPY 17.18B 7.02B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Esperion Therapeutics USD -29.52M 32.4M 2024-09
Exelixis USD 193.58M 8.73M 2025-09
Gilead Sciences USD 2.18B 869M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
Grifols EUR 148.4M 15.76M 2025-09
Halozyme Therapeutics USD 175.22M 10.06M 2025-09
Incyte USD 299.28M 124.89M 2025-12
Ionis Pharmaceuticals USD -128.61M 252.16M 2025-09
Ironwood Pharmaceuticals USD 3.19M 457K 2024-12
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
MacroGenics USD 16.82M 53.07M 2025-09
Merck USD 2.96B 2.82B 2025-12
Nektar Therapeutics USD -37.06M 15.31M 2024-09
Neurocrine Biosciences USD 209.5M 102M 2025-09
Novartis USD 3.93B 96M 2025-09
Pfizer USD -1.65B 5.19B 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sarepta Therapeutics USD -179.95M 376.84M 2025-09
Takeda JPY 103.64B 115.44B 2025-12
Teva Pharmaceutical Industries USD 480M 47M 2025-12
Xencor USD -6.03M 24.8M 2025-09


Nektar Therapeutics 净收入 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.